IL18 and neoplasm: Although most of these chronic models did not evaluate potential alterations in anti-tumor adaptive immunity, one study showed that in the absence of NLRP3 and caspase-1, reduced IL-18 in a colorectal tumor model led to diminished IFN-γ levels in the colon (214).